Both the Australian and US uranium stocks corrected sharply last week, and after taking profit from our Paladin (PDN) positions in our Active Growth and Emerging Companies Portfolios last month, along with Cameco (CCJ US) in The International Equities Portfolio, we might be re-entering sooner than we thought, i.e. MM always planned to buy dips in the uranium sector and its already testing levels which are interesting to MM. The last fortnight has seen Cameco fall -17% and Paladin -14%; another 5% would take them back into our buy zones.
- We can see Cameco Corp (CCJ US) rotating between $US40 and $US50 for a few months before adding to its post-COVID gains.